Drug Delivery最新文献

筛选
英文 中文
Correction. 更正。
IF 6 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-05-14 DOI: 10.1080/10717544.2024.2350273
{"title":"Correction.","authors":"","doi":"10.1080/10717544.2024.2350273","DOIUrl":"10.1080/10717544.2024.2350273","url":null,"abstract":"","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2350273"},"PeriodicalIF":6.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma. 用于治疗肝细胞癌的同型细胞膜伪装仿生聚乳酸(PLGA)纳米粒子。
IF 6 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-06-01 DOI: 10.1080/10717544.2024.2354687
Zhe Li, Jinshuai Lan, Ya Wu, Yue Ding, Tong Zhang
{"title":"Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma.","authors":"Zhe Li, Jinshuai Lan, Ya Wu, Yue Ding, Tong Zhang","doi":"10.1080/10717544.2024.2354687","DOIUrl":"10.1080/10717544.2024.2354687","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated death worldwide. Beside early detection, early diagnosis, and early surgery, it is urgent to try new strategies for the treatment of HCC. Triptolide (TPL) has been employed to treat HCC. However, its clinical applications were restricted by the narrow therapeutic window, severe toxicity, and poor water-solubility. In this study, we developed cancer cell membrane-camouflaged biomimetic PLGA nanoparticles loading TPL (TPL@mPLGA) with the homologous targeting property for the treatment of HCC. The TPL@mPLGA was successfully prepared with particle size of 195.5 ± 7.5 nm and zeta potential at -21.5 ± 0.2 mV with good stability. The drug loading (DL) of TPL@mPLGA was 2.94%. After Huh-7 cell membrane coating, the natural Huh-7 cell membrane proteins were found to be retained on TPL@mPLGA, thus endowing the TPL@mPLGA with enhanced accumulation at tumor site, and better anti-tumor activity <i>in vitro</i> and <i>in vivo</i> when compared with TPL or TPL@PLGA. The TPL@mPLGA showed enhanced anti-tumor effects and reduced toxicity of TPL, which could be adopted for the treatment of HCC.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2354687"},"PeriodicalIF":6.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11146252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141185798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fixation alters the physical properties of tumor tissue that regulate nanomedicine transport. 固定会改变肿瘤组织的物理特性,从而调节纳米药物的运输。
IF 6.5 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-11-20 DOI: 10.1080/10717544.2024.2430528
John D Martin, Fotios Mpekris, Vikash P Chauhan, Margaret R Martin, Megan E Walsh, Matthew D Stuber, Donald M McDonald, Fan Yuan, Triantafyllos Stylianopoulos, Rakesh K Jain
{"title":"Fixation alters the physical properties of tumor tissue that regulate nanomedicine transport.","authors":"John D Martin, Fotios Mpekris, Vikash P Chauhan, Margaret R Martin, Megan E Walsh, Matthew D Stuber, Donald M McDonald, Fan Yuan, Triantafyllos Stylianopoulos, Rakesh K Jain","doi":"10.1080/10717544.2024.2430528","DOIUrl":"10.1080/10717544.2024.2430528","url":null,"abstract":"<p><p>To have the desired therapeutic effect, nanomedicines and macromolecular medications must move from the site of injection to the site of action, without having adverse effects. Transvascular transport is a critical step of this navigation, as exemplified by the Enhanced Permeability and Retention (EPR) effect in solid tumors, not found in normal organs. Numerous studies have concluded that passive, diffusion- and convection-based transport predominates over active, cellular mechanisms in this effect. However, recent work using a new approach reevaluated this principle by comparing tumors with or without fixation and concluded the opposite. Here, we address the controversy generated by this new approach by reporting evidence from experimental investigations and computer simulations that separate the contributions of active and passive transport. Our findings indicate that tissue fixation reduces passive transport as well as active transport, indicating the need for new methods to distinguish the relative contributions of passive and active transport.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2430528"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11583359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bone scaffolds-based localized drugs delivery for osteosarcoma: current status and future perspective. 基于骨支架的骨肉瘤局部给药:现状与未来展望。
IF 6.5 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-09-06 DOI: 10.1080/10717544.2024.2391001
Wenqing Liang, Hengguo Long, Hongwei Zhang, Juqin Bai, Bo Jiang, Jiangwei Wang, Lifeng Fu, Wenyi Ming, Jiayi Zhao, Bin Zeng
{"title":"Bone scaffolds-based localized drugs delivery for osteosarcoma: current status and future perspective.","authors":"Wenqing Liang, Hengguo Long, Hongwei Zhang, Juqin Bai, Bo Jiang, Jiangwei Wang, Lifeng Fu, Wenyi Ming, Jiayi Zhao, Bin Zeng","doi":"10.1080/10717544.2024.2391001","DOIUrl":"10.1080/10717544.2024.2391001","url":null,"abstract":"<p><p>A common malignant bone neoplasm in teenagers is Osteosarcoma. Chemotherapy, surgical therapy, and radiation therapy together comprise the usual clinical course of treatment for Osteosarcoma. While Osteosarcoma and other bone tumors are typically treated surgically, however, surgical resection frequently fails to completely eradicate tumors, and in turn becomes the primary reason for postoperative recurrence and metastasis, ultimately leading to a high rate of mortality. Patients still require radiation and/or chemotherapy after surgery to stop the spread of the tumor and its metastases, and both treatments have an adverse influence on the body's organ systems. In the postoperative management of osteosarcoma, bone scaffolds can load cargos (growth factors or drugs) and function as drug delivery systems (DDSs). This review describes the different kinds of bone scaffolds that are currently available and highlights key studies that use scaffolds as DDSs for the treatment of osteosarcomas. The discussion also includes difficulties and perspectives regarding the use of scaffold-based DDSs. The study may serve as a source for outlining efficient and secure postoperative osteosarcoma treatment plans.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2391001"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11382735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the use of local anesthetic extended-release systems in pain management. 局麻药缓释系统在疼痛治疗中的应用进展。
IF 6 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2023-12-21 DOI: 10.1080/10717544.2023.2296349
Yulu Chen, Jingmei Xu, Ping Li, Liyang Shi, Sha Zhang, Qulian Guo, Yong Yang
{"title":"Advances in the use of local anesthetic extended-release systems in pain management.","authors":"Yulu Chen, Jingmei Xu, Ping Li, Liyang Shi, Sha Zhang, Qulian Guo, Yong Yang","doi":"10.1080/10717544.2023.2296349","DOIUrl":"10.1080/10717544.2023.2296349","url":null,"abstract":"<p><p>Pain management remains among the most common and largely unmet clinical problems today. Local anesthetics play an indispensable role in pain management. The main limitation of traditional local anesthetics is the limited duration of a single injection. To address this problem, catheters are often placed or combined with other drugs in clinical practice to increase the time that local anesthetics act. However, this method does not meet the needs of clinical analgesics. Therefore, many researchers have worked to develop local anesthetic extended-release types that can be administered in a single dose. In recent years, drug extended-release systems have emerged dramatically due to their long duration and efficacy, providing more possibilities for the application of local anesthetics. This paper summarizes the types of local anesthetic drug delivery systems and their clinical applications, discusses them in the context of relevant studies on local anesthetics, and provides a summary and outlook on the development of local anesthetic extended-release agents.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2296349"},"PeriodicalIF":6.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10763865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138828831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction. 撤回声明。
IF 6 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2023-01-18 DOI: 10.1080/10717544.2022.2157535
{"title":"Statement of Retraction.","authors":"","doi":"10.1080/10717544.2022.2157535","DOIUrl":"10.1080/10717544.2022.2157535","url":null,"abstract":"","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":" ","pages":"1"},"PeriodicalIF":6.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11104690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9091173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction: Bicomponent polymeric micelles for pH-controlled delivery of doxorubicin. 撤回声明:双组分聚合物胶束用于多柔比星的 pH 值控制给药。
IF 6 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-06-10 DOI: 10.1080/10717544.2024.2355035
{"title":"Statement of Retraction: Bicomponent polymeric micelles for pH-controlled delivery of doxorubicin.","authors":"","doi":"10.1080/10717544.2024.2355035","DOIUrl":"10.1080/10717544.2024.2355035","url":null,"abstract":"","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2355035"},"PeriodicalIF":6.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141295789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genistein transfersome-embedded topical delivery system for skin melanoma treatment: in vitro and ex vivo evaluations. 用于治疗皮肤黑色素瘤的基因istein转移体嵌入式局部给药系统:体外和体内评估。
IF 6.5 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-07-01 DOI: 10.1080/10717544.2024.2372277
Amira Motawea, Sara N Maria, Doaa N Maria, Monica M Jablonski, Mohamed Moustafa Ibrahim
{"title":"Genistein transfersome-embedded topical delivery system for skin melanoma treatment: <i>in vitro</i> and <i>ex vivo</i> evaluations.","authors":"Amira Motawea, Sara N Maria, Doaa N Maria, Monica M Jablonski, Mohamed Moustafa Ibrahim","doi":"10.1080/10717544.2024.2372277","DOIUrl":"10.1080/10717544.2024.2372277","url":null,"abstract":"<p><p>Skin melanoma is considered the most dangerous form of skin cancer due to its association with high risk of metastasis, high mortality rate and high resistance to different treatment options. Genistein is a natural isoflavonoid with known chemotherapeutic activity. Unfortunately, it has low bioavailability due to its poor aqueous solubility and excessive metabolism. In the current study, genistein was incorporated into transferosomal hydrogel to improve its bioavailability. The prepared transferosomal formulations were characterized regarding: particle size; polydispersity index; zeta potential; encapsulation efficiency; TEM; FTIR; DSC; XRD; <i>in vitro</i> drug release; viscosity; pH; <i>ex vivo</i> anti-tumor activity on 3D skin melanoma spheroids and 1-year stability study at different storage temperatures. The optimized formulation has high encapsulation efficiency with an excellent particle size that will facilitate its penetration through the skin. The transfersomes have a spherical shape with sustained drug release profile. The anti-tumor activity evaluation of genistein transfersome revealed that genistein is a potent chemotherapeutic agent with enhanced penetration ability through the melanoma spheroids when incorporated into transfersomes. Stability study results demonstrate the high physical and chemical stability of our formulations. All these outcomes provide evidence that our genistein transferosomal hydrogel is a promising treatment option for skin melanoma.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2372277"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11221477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suspensions of antibiotics in self-emulsifying oils as a novel approach to formulate eye drops with substances which undergo hydrolysis in aqueous environment. 抗生素在自乳化油中的悬浮液是一种新方法,可用于配制含有在水环境中会水解的物质的滴眼液。
IF 6.5 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-07-11 DOI: 10.1080/10717544.2024.2372279
Katarzyna Krzeminska, Malgorzata Sznitowska, Magdalena Wroblewska, Eliza Wolska, Katarzyna Winnicka
{"title":"Suspensions of antibiotics in self-emulsifying oils as a novel approach to formulate eye drops with substances which undergo hydrolysis in aqueous environment.","authors":"Katarzyna Krzeminska, Malgorzata Sznitowska, Magdalena Wroblewska, Eliza Wolska, Katarzyna Winnicka","doi":"10.1080/10717544.2024.2372279","DOIUrl":"10.1080/10717544.2024.2372279","url":null,"abstract":"<p><p>The aim of this study was to develop eye-drops with cefuroxime (CEF) sodium or vancomycin (VAN) hydrochloride, antibiotics that are instable in water. Anhydrous self-emulsifying oils (SEO) are proposed as a carrier and antibiotics are suspended. In the contact with tear fluid, the formulation should transform into emulsion, with fast dissolution of an antibiotic. CEF or VAN (5% w/w) was suspended in SEO carriers prepared by dissolving surfactants (Tween 20 or Span 80 5% w/w) in Miglyol, castor oil, or olive oil. Formulations with or without sodium citrate (2% w/w) were compared. Six-months or 1-year stability tests were carried out at 40 °C. The content of CEF and VAN was evaluated using HPLC and the potency of the antibiotic was assessed with agar diffusion method. In contact with water, drug particles suspended in SEO dissolved rapidly and o/w emulsion was formed. After 1-year at 40 °C, the content of degradation products was at most 0.5% in CEF and 4.0% in VAN formulations. The agar diffusion assay has shown that CEF and VAN loaded into SEO retained its potency against the sensitive microorganisms comparable to an aqueous solution. Therefore, SEO can be used as a novel carrier for the active substances which may not require improved solubility or absorption but need to be protected from moisture. This is a formulation that can be produced on industrial scale, with no limitation of stability or drug concentration.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2372279"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141589887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing burn wound treatment: exploring hydrogel as a transdermal drug delivery system. 推进烧伤创面治疗:探索水凝胶作为透皮给药系统。
IF 6.5 2区 医学
Drug Delivery Pub Date : 2024-12-01 Epub Date: 2024-02-16 DOI: 10.1080/10717544.2023.2300945
MeeiChyn Goh, Meng Du, Wang Rui Peng, Phei Er Saw, Zhiyi Chen
{"title":"Advancing burn wound treatment: exploring hydrogel as a transdermal drug delivery system.","authors":"MeeiChyn Goh, Meng Du, Wang Rui Peng, Phei Er Saw, Zhiyi Chen","doi":"10.1080/10717544.2023.2300945","DOIUrl":"10.1080/10717544.2023.2300945","url":null,"abstract":"<p><p>Burn injuries are prevalent and life-threatening forms that contribute significantly to mortality rates due to associated wound infections. The management of burn wounds presents substantial challenges. Hydrogel exhibits tremendous potential as an ideal alternative to traditional wound dressings such as gauze. This is primarily attributed to its three-dimensional (3D) crosslinked polymer network, which possesses a high water content, fostering a moist environment that supports effective burn wound healing. Additionally, hydrogel facilitates the penetration of loaded therapeutic agents throughout the wound surface, combating burn wound pathogens through the hydration effect and thereby enhancing the healing process. However, the presence of eschar formation on burn wounds obstructs the passive diffusion of therapeutics, impairing the efficacy of hydrogel as a wound dressing, particularly in cases of severe burns involving deeper tissue damage. This review focuses on exploring the potential of hydrogel as a carrier for transdermal drug delivery in burn wound treatment. Furthermore, strategies aimed at enhancing the transdermal delivery of therapeutic agents from hydrogel to optimize burn wound healing are also discussed.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"31 1","pages":"2300945"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10878343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139746436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信